SONOMA PHARMACEUTICALS, INC. (SNOA) Net margin 2017–2026
SONOMA PHARMACEUTICALS, INC. (SNOA) net profit margin by fiscal year — reported net income divided by reported revenue.
-16.3%FY2026 · since FY2017: 72.3% → -16.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -16.3% | +7.9 pp |
| FY2025 | -24.2% | +13.8 pp |
| FY2024 | -38.0% | +0.8 pp |
| FY2023 | -38.8% | +1.5 pp |
| FY2022 | -40.3% | -19.1 pp |
| FY2021 | -21.2% | -2.8 pp |
| FY2020 | -18.5% | +43.7 pp |
| FY2019 | -62.2% | +23.8 pp |
| FY2018 | -86.0% | -158.3 pp |
| FY2017 | 72.3% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice